← Eichor
Study identifier: NCT06898086 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Transfemoral TAVI With or Without Coronary Angiogram in Patients With Severe Aortic Stenosis (PURE TAVI)

Condition: Severe Aortic Stenosis  ·  Sponsor: Rede Optimus Hospitalar SA

PhaseNA
Planned participants620
Who can joinAll sexes, 18 Years to 120 Years
Healthy volunteersNo

About this study

This study will be conducted in patients with severe aortic stenosis who are referred for transcatheter aortic valve implantation (TAVI). TAVI is the recommended treatment for severe aortic stenosis. Currently, before undergoing TAVI, most patients undergo a coronary angiography to check whether the coronary arteries are blocked and to assist in appropriate valve sizing. If significant blockages are detected, they are treated before or during TAVI. However, many patients who undergo TAVI are older and often have additional cardiovascular conditions such as hypertension, diabetes, or obesity. These comorbidities increase the risk of complications related to coronary angiography, including kidney injury from contrast dye, bleeding, and vascular complications at the access site. As such, it remains uncertain whether routine coronary angiography is necessary for all patients undergoing TAVI, particularly those without symptoms suggestive of myocardial ischemia. This study aims to determine whether a TAVI treatment pathway without prior coronary angiography is non-inferior to the standard pathway that includes routine coronary angiography, with or without revascularization, in patients with severe aortic stenosis who do not have typical angina symptoms (defined as Canadian Cardiovascular Society Class \<3). "Non-inferior" means the study seeks to show that omitting routine coronary angiography is at least as effective and safe as the standard approach. All participants will rec…

This description comes directly from the study's public registry record.

Talk to the study team

Julie Bosiers  ·  +32 479 64 37 60  ·  julie.bosiers@redeoptimus.com

Gavin Vaz  ·  04917615203936  ·  gavin.vaz@redeoptimus.com

Always discuss trial participation with your own doctor first.

Locations (23)

Medical University GrazGraz, AustriaRecruiting
Klinikum Klagenfurt am WörtherseeKlagenfurt, AustriaNot Yet Recruiting
Královské Vinohrady University HospitalPrague, CzechiaNot Yet Recruiting
Nemocnice Na HomolcePrague, CzechiaNot Yet Recruiting
Institut Arnault TzanckNice, FranceNot Yet Recruiting
Clinique PasteurToulouse, FranceNot Yet Recruiting
Universitätsklinikum DüsseldorfDüsseldorf, North Rhine-Westphalia, GermanyNot Yet Recruiting
Elisabeth Krankenhaus EssenEssen, GermanyNot Yet Recruiting
Universitätsklinikum Freiburg- Universitäts-Herzzentrum Campus Bad KrozingenFreiburg im Breisgau, GermanyNot Yet Recruiting
Universitätsklinikum Schleswig-Holstein - Campus LübeckLübeck, GermanyNot Yet Recruiting
Universitätsklinikum UlmUlm, GermanyNot Yet Recruiting
IRCCS ISMETT PalermoPalermo, Basel-Stadt, ItalyNot Yet Recruiting

+ 11 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06898086